These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 11764092)

  • 1. White matter extracellular matrix chondroitin sulfate/dermatan sulfate proteoglycans in multiple sclerosis.
    Sobel RA; Ahmed AS
    J Neuropathol Exp Neurol; 2001 Dec; 60(12):1198-207. PubMed ID: 11764092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The extracellular matrix in multiple sclerosis: an update.
    Sobel RA
    Braz J Med Biol Res; 2001 May; 34(5):603-9. PubMed ID: 11323746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The extracellular matrix in multiple sclerosis lesions.
    Sobel RA
    J Neuropathol Exp Neurol; 1998 Mar; 57(3):205-17. PubMed ID: 9600212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The regulated synthesis of versican, decorin, and biglycan: extracellular matrix proteoglycans that influence cellular phenotype.
    Kinsella MG; Bressler SL; Wight TN
    Crit Rev Eukaryot Gene Expr; 2004; 14(3):203-34. PubMed ID: 15248816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remodeling of the interstitial extracellular matrix in white matter multiple sclerosis lesions: Implications for remyelination (failure).
    de Jong JM; Wang P; Oomkens M; Baron W
    J Neurosci Res; 2020 Jul; 98(7):1370-1397. PubMed ID: 31965607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decorin, a chondroitin/dermatan sulfate proteoglycan is under neural control in rat skeletal muscle.
    Brandan E; Fuentes ME; Andrade W
    J Neurosci Res; 1992 May; 32(1):51-9. PubMed ID: 1629944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lectican proteoglycans, their cleaving metalloproteinases, and plasticity in the central nervous system extracellular microenvironment.
    Howell MD; Gottschall PE
    Neuroscience; 2012 Aug; 217():6-18. PubMed ID: 22626649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical localization of chondroitin sulphate and dermatan sulphate proteoglycans in tumour tissues.
    Fukatsu T; Sobue M; Nagasaka T; Ohiwa N; Fukata S; Nakashima N; Takeuchi J
    Br J Cancer; 1988 Jan; 57(1):74-8. PubMed ID: 3348950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chondroitin sulfate proteoglycans in the developing central nervous system. II. Immunocytochemical localization of neurocan and phosphacan.
    Meyer-Puttlitz B; Junker E; Margolis RU; Margolis RK
    J Comp Neurol; 1996 Feb; 366(1):44-54. PubMed ID: 8866845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pro-inflammatory roles of chondroitin sulfate proteoglycans in disorders of the central nervous system.
    Stephenson EL; Yong VW
    Matrix Biol; 2018 Oct; 71-72():432-442. PubMed ID: 29702175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chondroitin sulphate proteoglycans: extracellular matrix proteins that regulate immunity of the central nervous system.
    Haylock-Jacobs S; Keough MB; Lau L; Yong VW
    Autoimmun Rev; 2011 Oct; 10(12):766-72. PubMed ID: 21664302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural variability of large and small chondroitin sulphate/dermatan sulphate proteoglycans.
    Heinegård D; Hedbom E; Antonsson P; Oldberg A
    Biochem Soc Trans; 1990 Apr; 18(2):209-12. PubMed ID: 2199261
    [No Abstract]   [Full Text] [Related]  

  • 13. Lecticans: organizers of the brain extracellular matrix.
    Yamaguchi Y
    Cell Mol Life Sci; 2000 Feb; 57(2):276-89. PubMed ID: 10766023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The extracellular matrix: Focus on oligodendrocyte biology and targeting CSPGs for remyelination therapies.
    Pu A; Stephenson EL; Yong VW
    Glia; 2018 Sep; 66(9):1809-1825. PubMed ID: 29603376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of chondroitin sulfate and dermatan sulfate proteoglycans of extracellular matrices of human umbilical cord blood vessels and Wharton's jelly.
    Valiyaveettil M; Achur RN; Muthusamy A; Gowda DC
    Glycoconj J; 2004; 21(6):361-75. PubMed ID: 15514483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiology of the brain extracellular matrix: a new target for remyelination.
    Lau LW; Cua R; Keough MB; Haylock-Jacobs S; Yong VW
    Nat Rev Neurosci; 2013 Oct; 14(10):722-9. PubMed ID: 23985834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective deposits of versican in the extracellular matrix of restenotic lesions from human peripheral arteries.
    Wight TN; Lara S; Riessen R; Le Baron R; Isner J
    Am J Pathol; 1997 Oct; 151(4):963-73. PubMed ID: 9327730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta induces a chondroitin sulfate/dermatan sulfate proteoglycan in alveolar type II cells.
    Maniscalco WM; Campbell MH
    Am J Physiol; 1994 Jun; 266(6 Pt 1):L672-80. PubMed ID: 8023956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overcoming neurite-inhibitory chondroitin sulfate proteoglycans in the astrocyte matrix.
    Cua RC; Lau LW; Keough MB; Midha R; Apte SS; Yong VW
    Glia; 2013 Jun; 61(6):972-84. PubMed ID: 23554135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of specific binding sites for keratan sulphate proteoglycans and chondroitin-dermatan sulphate proteoglycans on collagen fibrils in cornea by the use of cupromeronic blue in 'critical-electrolyte-concentration' techniques.
    Scott JE; Haigh M
    Biochem J; 1988 Jul; 253(2):607-10. PubMed ID: 2972275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.